News Releases - Tumor biology

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
    • Filter by program
    About Ludwig Cancer genomics Cancer prevention Tumor biology Tumor immunology Tumor microenvironment
    View All
    Three Ludwig Harvard and MIT researchers elected members of the National Academy of Medicine
    October 22, 2024
    New strategy to tackle triple-negative breast cancer
    October 9, 2024
    Ludwig Harvard scientists discover new target for potential leukemia therapy
    May 8, 2024
    Ludwig Institute Scientific Director Chi Van Dang receives the 2024 AACR-Margaret Foti Award
    February 20, 2024
    Immunologist Lydia Lynch appointed member of Ludwig Princeton
    January 29, 2024
    How a timekeeping gene affects tumor growth depends entirely on context
    January 24, 2024
    Five Ludwig Cancer Research scientists elected Fellows of the American Association for Cancer Research
    January 17, 2024
    Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
    September 20, 2023
    Ludwig Chicago study develops an innovative approach to classify metastases in colorectal cancer patients
    July 20, 2023
    Ludwig Lausanne’s Douglas Hanahan elected Foreign Member of the Royal Society
    May 10, 2023
    Ludwig MIT researchers devise a portable nanotech-based test for cancer detection and diagnostics
    April 25, 2023
    Ludwig Cancer Research scientists to present at AACR Annual Meeting
    April 17, 2023
    Ludwig Princeton study finds cancers are metabolically sluggish and thrifty
    February 1, 2023
    Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors
    January 23, 2023
    Richard White joins Ludwig Oxford Branch
    October 14, 2022
    Ludwig Princeton’s Eileen White named co-leader of $25 million Cancer Grand Challenges team tackling cancer cachexia
    June 16, 2022
    Ludwig MSK study modeling tumor evolution reveals a vulnerability for cancer prevention and therapy
    May 11, 2022
    Ludwig Cancer Research scientists to present advances in cancer immunotherapy, metastasis, diagnostics and more at 2022 AACR Annual Meeting
    April 4, 2022
    Four Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    March 23, 2022
    Ludwig Stanford study solves long-sought protein structure, shows how mutation drives blood cancers
    March 10, 2022
    Ludwig Princeton preclinical study shows ketogenic diet could enhance pancreatic cancer therapy
    February 11, 2022
    Counting cells may shed light on how cancer spreads
    September 28, 2021
    Ludwig MIT researchers devise noninvasive test to detect tumors and pinpoint their location
    July 15, 2021
    Ludwig Cancer Research study reveals even transient chromosomal mistakes can initiate cancer
    July 15, 2021
    Ludwig Cancer Research study employs novel drug screen to identify a potential individualized triple-negative breast cancer therapy
    June 8, 2021
    Ludwig Princeton’s Eileen White and Ludwig Harvard’s Alan D’Andrea elected to National Academy of Sciences
    April 28, 2021
    Ludwig Cancer Research study shows pancreatic cancer cells hit reverse to advance in malignancy
    April 28, 2021
    Ludwig Cancer Research opens new Branch dedicated to cancer metabolism at Princeton University
    April 13, 2021
    Ludwig Cancer Research scientists to present advances in immunotherapy, cancer metabolism, metastasis and detection at first AACR Annual Meeting 2021
    April 10, 2021
    Two Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    March 29, 2021
    Ludwig Cancer Research study reveals how certain gut bacteria compromise radiotherapy
    January 26, 2021
    Ludwig Cancer Research study reveals how circular ecDNA is generated and drives drug resistance in cancer
    December 23, 2020
    Ludwig Lausanne receives Team Science Award from the Society for Immunotherapy of Cancer
    November 14, 2020
    Ludwig study finds a common nutritional supplement might boost the effects of cancer immunotherapy
    October 5, 2020
    Ludwig study shows how loss of a single gene fuels a childhood brain cancer
    September 11, 2020
    Ludwig Chicago study identifies a novel drug target for the control of cancer metastasis
    August 24, 2020
    Ludwig study shows free-floating circles of DNA are common across cancers and drive poor patient outcomes
    August 20, 2020
    Ludwig Harvard study identifies novel mechanism driving triple-negative breast cancers – and potential targets for therapy
    August 3, 2020
    Ludwig San Diego study identifies deadly genetic synergy in cancer cells and shows it might be exploited for therapy
    July 27, 2020
    Ludwig Cancer Research mourns the death of Sanjiv Sam Gambhir
    July 20, 2020
    Juanita L. Merchant appointed to the Ludwig Institute’s Scientific Advisory Committee
    July 14, 2020
    Five Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    May 14, 2020
    Ludwig Oxford Director Xin Lu elected to the Royal Society
    April 29, 2020
    Ludwig Harvard Co-Director George Demetri wins Karnofsky Award
    April 24, 2020
    Nanosensors for early detection of lung cancer
    April 2, 2020
    Targeting turncoat immune cells to treat cancer
    February 17, 2020
    Dismantling drug resistance in colorectal cancer
    February 5, 2020
    Douglas Hanahan appointed Distinguished Scholar of the Ludwig Institute for Cancer Research
    January 14, 2020
    Ping-Chih Ho appointed Associate Member of Ludwig Institute for Cancer Research
    January 9, 2020
    Ludwig Lausanne’s Ping-Chih Ho named an EMBO Young Investigator
    November 13, 2019
    A new pathway for lung cancer treatment
    November 12, 2019
    Ludwig Harvard study reveals how non-mutational changes to the genome drive a type of cancer
    October 16, 2019
    Ludwig Oxford’s Sir Peter Ratcliffe wins Nobel Prize
    October 7, 2019
    Aggressive brain cancers tap into neural wiring to thrive
    September 27, 2019
    New ‘don’t eat me’ signal may provide basis for cancer therapies
    July 31, 2019
    Test promises to improve identification of precancerous pancreatic cysts
    July 17, 2019
    Ludwig study establishes cancer-driving role of enzyme that alters the membrane of cancer cells
    July 12, 2019
    Ludwig Stanford researchers borrow from sports playbook to predict cancer outcomes
    July 9, 2019
    Ludwig study uncovers novel cellular oxygen sensor
    July 5, 2019
    Normalizing the tumor microenvironment to improve immunotherapy of cancer
    June 19, 2019
    Ludwig antibody 806 may work against a variety of EGF receptor-driven cancers
    May 20, 2019
    Nanobodies to detect and target tumors
    May 15, 2019
    New computational tool enables powerful molecular analysis of biomedical tissue samples
    May 7, 2019
    Researchers at the Ludwig Center at Harvard demonstrate arsenic-based therapy can reverse drug tolerance in acute myeloid leukemia
    April 30, 2019
    Studying cell lineage in tumors reveals targetable vulnerabilities
    April 24, 2019
    Spotting a malignant signature
    April 17, 2019
    A small RNA plays a big role in lung cancer drug resistance
    April 12, 2019
    Modified immune cells issue alert when detecting cancer in mice
    March 19, 2019
    Dietary supplement could improve treatment of some blood cancers
    March 7, 2019
    An atlas of an aggressive leukemia
    February 28, 2019
    Blocking a protein may improve a brain tumor’s sensitivity to radiotherapy
    February 28, 2019
    Utilizing molecular imaging technologies to predict, monitor and optimize immunotherapies
    February 20, 2019
    Antibody could increase cure rate for blood, immune disorders
    February 15, 2019
    From microfluidics to metastasis
    January 28, 2019
    Solid stress from brain tumors causes neuronal loss, neurologic dysfunction
    January 9, 2019
    ‘Chemo brain’ caused by malfunction in three types of brain cells
    December 13, 2018
    Clinical research in an era of disease-agnostic basket trials
    October 19, 2018
    Johanna Joyce appointed Member of Ludwig Institute for Cancer Research, Lausanne
    October 4, 2018
    Study of rare cancer yields therapeutic clues to combat drug resistance
    August 31, 2018
    A “non-canonical” strategy may improve cancer radiotherapy
    August 29, 2018
    Ludwig-developed candidate cancer drug may be effective against broader class of brain cancers
    July 9, 2018
    ASCO to honor Ludwig scientists at 2018 annual meeting
    May 30, 2018
    Why hushing the ‘wasabi receptor’ might aid breast cancer treatment
    May 24, 2018
    Ludwig study confirms curable state between localized and systemic cancers
    May 7, 2018
    Ludwig scientists share new findings on personalized cancer treatments, immunotherapy and the tumor microenvironment at 2018 AACR annual meeting
    April 11, 2018
    Ludwig presence at 2018 AACR annual meeting, April 11, 2018
    April 11, 2018
    Obesity may promote resistance to antiangiogenic therapy for breast cancer
    March 19, 2018
    Ludwig Stanford Professor Howard Chang honored with NAS award in molecular biology
    January 17, 2018
    Ludwig researchers uncover mechanism behind a metabolic vulnerability of certain breast cancers
    December 19, 2017
    Ludwig researchers unravel novel mechanism by which tumors grow resistant to radiotherapy
    November 23, 2017
    Ludwig scientists share findings on development and treatment of glioblastoma at the 2017 Society for Neuro-oncology Annual Meeting
    November 10, 2017
    Ludwig presence at the 2017 Society for Neuro-oncology Annual Meeting
    November 10, 2017
    Why some people with pancreatic cancer live longer than others
    November 9, 2017
    Ludwig scientists share insights on immunotherapy research at the 2017 Society for Immunotherapy of Cancer annual meeting
    November 6, 2017
    New study reveals breast cancer cells turn toxic waste into fuel
    October 24, 2017
    Convergence of the circadian clock and cancer
    October 19, 2017
    Scale and complexity of hypoxia signaling pathways and their implications for cancer
    October 10, 2017
    Ludwig welcomes W.K. Alfred Yung and Victor Velculescu to its Scientific Advisory Committee
    August 16, 2017
    A swell diagnostic method
    July 17, 2017
    Ludwig researchers present new findings on combination immunotherapy and other research at the 2017 ASCO Annual Meeting
    May 31, 2017
    Ludwig presence at 2017 ASCO annual meeting
    May 30, 2017
    New clue to treating a lethal breast cancer metastasis
    May 24, 2017
    Ludwig researchers identify counterintuitive approach to treating a brain cancer
    May 12, 2017
    Robert L. Strausberg appointed Deputy Scientific Director of the Ludwig Institute for Cancer Research
    April 26, 2017
    Ludwig scientists reveal new advances in immunotherapy, predictive biomarkers and overcoming treatment resistance at 2017 AACR annual meeting
    March 29, 2017
    New study finds that most cancer mutations are due to random DNA copying errors
    March 23, 2017
    A vulnerability in triple-negative breast cancer could improve treatment outcomes
    March 2, 2017
    New Ludwig research will shift how cancer diversity and resistance are understood and studied
    February 8, 2017
    Coaxing leukemia cells into an embryonic state
    January 12, 2017
    Chi Van Dang appointed Scientific Director of the Ludwig Institute for Cancer Research
    December 20, 2016
    Ludwig congratulates its Breakthrough Prize winners Stephen Elledge and Roeland Nusse
    December 6, 2016
    Existing drug may be effective against a common subtype of lung cancer
    December 6, 2016
    Ludwig studies could help improve experimental stem cell therapies for Parkinson’s disease
    November 1, 2016
    Ludwig researchers develop a new way to evaluate aggressiveness of bladder cancer
    October 24, 2016
    Ludwig researchers find withholding an amino acid from diet depletes blood stem cells
    October 20, 2016
    The circuitry of metastasis
    October 20, 2016
    Ludwig researchers show how a brain tumor’s greed for cholesterol could be exploited for cancer therapy
    October 13, 2016
    Ludwig’s Webster Cavenee honored with 2016 Chinese Government Friendship Award
    October 4, 2016
    Ludwig study exposes key requirement for regulatory T cell function
    September 22, 2016
    Ludwig congratulates Sir Peter Ratcliffe on his receipt of the 2016 Albert Lasker Basic Medical Research Award
    September 13, 2016
    Ludwig study provides important insight into circuitry of cancer cell metastasis
    August 30, 2016
    A safer way for bone marrow transplants
    August 10, 2016
    Ludwig researchers discover how cancer cells gum up the trigger of a T cell attack
    July 26, 2016
    New screening test using blood biomarkers may identify risk of colon cancer recurrence early
    July 6, 2016
    Steroid receptor crosstalk informs therapies for breast cancer
    June 28, 2016
    Radiation and vaccination can magnify effects of immunotherapy
    June 14, 2016
    Ludwig researchers showcase new findings on immunotherapy, liquid biopsies and other aspects of cancer care at the 2016 Annual Meeting of the American Society of Clinical Oncology
    June 2, 2016
    Ludwig Presence at 2016 ASCO annual meeting
    June 2, 2016
    Two Ludwig scientists elected to National Academy of Sciences
    May 4, 2016
    Ludwig Uppsala Director Carl-Henrik Heldin elected to the American Academy of Arts and Sciences
    April 21, 2016
    Ludwig researchers showcase new findings on immunotherapy, liquid biopsies and other aspects of cancer care at the 2016 Annual Meeting of the American Society of Clinical Oncology
    April 12, 2016
    Ludwig presence at the 2016 AACR annual meeting
    April 12, 2016
    A different route to drug resistance
    April 11, 2016
    Ludwig Cancer Research Scientific Director David Lane named AACR Fellow
    April 5, 2016
    Ludwig scientists named to Thomson Reuters’ list of world’s most influential scientific minds
    February 18, 2016
    Statement by Ludwig Cancer Research on Vice President Biden’s National Cancer Moonshot Initiative
    February 1, 2016
    Gene often lost in childhood cancer crucial in cells’ life or death decision
    January 25, 2016
    Chemotherapy after surgery may benefit an identifiable subgroup of stage-2 colon cancer patients
    January 20, 2016
    Pharmacogenomics
    January 20, 2016
    Ludwig San Diego’s Paul Mischel elected Fellow of the American Association for the Advancement of Science
    November 23, 2015
    RNA-based drugs give more control over gene editing
    November 16, 2015
    An agile challenge to brain cancer
    November 12, 2015
    Ludwig Johns Hopkins co-director Kenneth Kinzler elected to National Academy of Medicine
    October 19, 2015
    Immunomodulation of the tumor microenvironment
    October 16, 2015
    A convergence of deadly signals
    October 8, 2015
    Nutrients turn on key tumor signaling molecule, fueling resistance to cancer therapy, Ludwig Cancer Research study shows
    July 13, 2015
    Ludwig Cancer Research and University of Oxford launch cancer immunotherapy spinout
    July 9, 2015
    DNA shed from head and neck tumors detected in blood and saliva
    June 24, 2015
    Ludwig presence at Ludwig scientists to report advances in treatment of brain, skin, gastrointestinal cancers at 2015 ASCO annual meeting
    May 26, 2015
    Ludwig presence at 2015 ASCO annual meeting
    May 22, 2015
    Settling an old debate
    April 30, 2015
    Ludwig’s Tyler Jacks speaks about mouse models and use of genome-editing tools to hasten discovery in cancer research
    April 19, 2015
    Ludwig scientists to present advancements in immunotherapy, diagnostics, cell biology and genomics at 2015 AACR annual meeting
    April 14, 2015
    Ludwig presence at 2015 AACR annual meeting
    April 13, 2015
    Reconstructing a smoothie
    March 31, 2015
    Unraveling glioblastoma’s resistance
    March 18, 2015
    Dialing a bespoke signal
    March 16, 2015
    Keeping tumors in check
    February 3, 2015
    Peter S. Kim named the Virginia and D.K. Ludwig Professor of Biochemistry at Stanford
    January 13, 2015
    The STING of radiation
    November 20, 2014
    Ludwig Oxford’s Mads Gyrd-Hansen named an EMBO Young Investigator
    November 12, 2014
    Sebastian Nijman appointed associate member of Ludwig Oxford
    November 4, 2014
    A switch to dampen malignancy
    October 26, 2014
    Eighty per cent of bowel cancers may be susceptible to existing medicines
    October 1, 2014
    Ludwig Harvard Director Joan Brugge receives Susan G. Komen Brinker Award for Scientific Distinction
    September 10, 2014
    New ways to treat solid tumors
    August 15, 2014
    Modification of tumor suppressor affects sensitivity to potential glioblastoma treatment
    August 14, 2014
    RaDAR guides proteins into the nucleus
    May 22, 2014
    Five Ludwig researchers named AACR fellows
    April 2, 2014
    Ludwig scientists to present advancements in immunotherapy, genomics and metastasis at 2014 AACR annual meeting
    April 2, 2014
    Ludwig presence at 2014 AACR annual meeting
    April 2, 2014
    Ludwig’s Webster Cavenee honored with AACR’S Margaret Foti Award
    March 17, 2014
    Silencing a silencer
    February 6, 2014
    Ludwig Oxford scientist Peter Ratcliffe receives Wiley Prize in Biomedical Sciences
    February 5, 2014
    Existing medicines show promise for treating stomach and bowel cancer
    February 4, 2014
    Ludwig Cancer Research bestows half a billion in new funding to six eminent U.S. research institutions
    January 6, 2014
    Ludwig Center directors comment on the impact of the $540 million gift from Ludwig Cancer Research
    January 6, 2014
    Cancer’s game of hide-and-seek
    December 5, 2013
    Cancer mutation likely trigger of scleroderma
    December 5, 2013
    Therapeutically exploiting cytokines that link inflammation to tumor progression
    November 13, 2013
    Targeting cancer’s sweet tooth
    October 21, 2013
    A genetic variation that could protect skin from sun damage fuels testicular cancer
    October 10, 2013
    Ludwig scientists at Johns Hopkins find promising therapeutic target for hard-to-treat brain tumor
    August 27, 2013
    ʻDark-horseʼ molecule is a potential new anti-cancer target
    August 12, 2013
    New insights into neuroblastoma tumor suppressor may provide clues for improved treatment
    August 12, 2013
    Genome sequencing proves herbal remedy causes upper urinary tract cancers
    August 7, 2013
    Researchers report a therapeutic strategy that appears to destroy drug resistant melanomas and suppress metastasis
    June 20, 2013
    Oncogene mutation hijacks splicing process to promote growth and survival
    May 31, 2013
    Professor Sir David Lane named scientific director of the Ludwig Institute for Cancer Research
    May 30, 2013
    New research reveals how the tumor suppressor p53 is shut down in metastatic melanoma—and how it can be revived
    April 25, 2013
    A check on tension—Ludwig discovery upends model for cell division
    April 22, 2013
    Ludwig Uppsala Director Carl-Henrik Heldin new chairman of the Nobel Foundation
    April 11, 2013
    Ludwig presents advancements in immunotherapy and epigenetics at AACR meeting
    April 10, 2013
    Researchers describe for the first time how certain brain tumors adapt to exploit normal cellular signaling pathways to develop drug resistance
    April 8, 2013
    Ludwig cancer researchers honored among first class of fellows in AACR Academy
    March 26, 2013
    Novel combination therapy shuts down escape route, killing glioblastoma tumor cells
    February 26, 2013
    Ludwig oncologist Vogelstein at Johns Hopkins receives $3 million life sciences award
    February 22, 2013
    Pathway controlling cell growth revealed
    February 18, 2013
    Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests, Stanford researchers say
    February 5, 2013
    Potential new treatment for gastrointestinal cancers discovered
    January 16, 2013
    Ludwig scientists at Johns Hopkins use pap test fluid to detect ovarian, endometrial cancers
    January 9, 2013
    Predictors of cancer disease progression could improve patient selection for metastasis-directed therapy
    December 12, 2012
    Ludwig Center scientists at Johns Hopkins pair blood test and gene sequencing to detect cancer
    November 29, 2012
    New oral drug overcomes resistance in patients with rare sarcoma after failure of standard targeted therapies
    November 22, 2012
    Distinguished researcher Peter Ratcliffe joins Ludwig Institute
    November 8, 2012
    Don W. Cleveland of the Ludwig Institute for Cancer Research elected to the Institute of Medicine
    October 15, 2012
    Study uncovers mechanism by which tumor suppressor Mig6 triggers cell suicide
    September 24, 2012
    Molecular switch identified that controls key cellular process and gives insights into cancer
    August 1, 2012
    Ludwig Institute for Cancer Research issues statement of support for Recepta Biopharma
    July 26, 2012
    Ludwig Institute joins new state-of-the-art comprehensive cancer center in Melbourne, Australia
    July 3, 2012
    The Ludwig Institute for Cancer Research highlights more than a dozen abstracts at the annual meeting of the American Society of Clinical Oncology
    June 1, 2012
    New Ludwig partnership in Brazil
    April 13, 2012
    Q&A with LICR Scientific Director Dr. Andrew Simpson in International Innovation
    April 3, 2012
    Ludwig Center Director Bert Vogelstein honored by AACR
    March 23, 2012
    Woman’s recovery from advanced melanoma could help guide research
    March 9, 2012
    New England Journal of Medicine study shows pairing immunotherapy with radiotherapy improves a patient’s ability to fight melanoma
    March 7, 2012
    Ludwig Institute for Cancer Research’s discovery leads to Australian patient trials
    March 6, 2012
    Perspective from Xin Lu, Oxford Branch director, in EMBO publication
    February 7, 2012
    Stanford computer algorithm used to identify bladder cancer marker
    January 18, 2012
    Anti-cancer vaccine using T. cruzi parasite prevents cancer in pre-clinical studies
    January 12, 2012
    Ludwig Institute partner company, Circadian, commences first phase 1 clinical trial of VEGF-C antibody VGX-100 in cancer patients
    January 10, 2012
    DNA mismatch repair happens only during a brief window of opportunity
    December 22, 2011
    Ludwig scientist shows molecular markers can predict spread of cancer, guide treatment
    December 15, 2011
    How brain tumors invade
    December 13, 2011
    Ludwig scientist discovers key mechanism in DNA repair
    December 5, 2011
    Ricardo Brentani, former Sao Paolo Branch director, passed away
    November 30, 2011
    Professor Ralf Petterson, former director of the Ludwig Institute for Cancer Research in Stockholm, passed away on November 3rd
    November 14, 2011
    Director of LICR Oxford Branch, Professor Xin Lu, PhD FRCPath, Elected to European Molecular Biology Organization
    October 21, 2011
       Back to News

    Stay In Touch

    Notice
    ?

    You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

    Continue
    Cancel